echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > NEJM: Anti-new coronary antibody titration did not decrease within 4 months.

    NEJM: Anti-new coronary antibody titration did not decrease within 4 months.

    • Last Update: 2020-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In the study, conducted by researchers at Amgen's gene decoding company (deCODE genetics) and its partners, researchers tested serum samples from 30,576 Icelanders in six tests and a four-month serological follow-up test from 1,237 patients who were confirmed to have been infected with the new coronavirus through nucleic acid testing.
    trial results showed that out of 1,215 recovered patients, 1,107 patients had antibodies (91.1%) against the new coronavirus in their serum.
    It's worth noting that in recovering patients with antibodies in these serums, using two pan-IgG antibody tests, the researchers found that the antibody titer of the antibody binding domain (S1-RBD), which targets the new coronavirus N protein and the target neo-coronavirus prickly protein binding domain (S1-RBD), did not decrease significantly within 4 months of confirmation of infection.
    results are different from some previously published studies.
    Antibody titrations targeting the new coronavirus N protein and S1-RBD protein did not decrease within four months of diagnosis (Photo source: References. 3) The researchers note in a discussion of the article that a variety of factors may have led to differences between the study and previous studies, including the specificity and sensitivity of the detection method, the type of antigen detected, and the patient group characteristics studied.
    , for example, because of extensive nucleic acid testing and screening, many of Iceland's nucleic acid-positive populations are diagnosed with no symptoms and may be healthier than the patient population in other studies.
    also point out that more populations still need to be studied using proven quantitative antibody testing.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.